MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway

MDFI promotes the proliferation and tolerance to chemotherapy of colorectal cancer cells by binding ITGB4/LAMB3 to activate the AKT signaling pathway

Colorectal cancer (CRC) is one of the most lethal cancers. Single-cell RNA sequencing (scRNA-seq) and protein-protein interactions (PPIs) have enabled the systematic study of CRC. In our research, the activation of the AKT pathway in CRC was analyzed by KEGG using single-cell sequencing data from th...

Full description

Bibliographic Details
Main Authors: Ding Ma, Shuwen Liu, Kua Liu, Lingkai Kong, Lingjun Xiao, Qilei Xin, Chunping Jiang, Junhua Wu
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Cancer Biology & Therapy
Subjects:
scRNA-seq (single-cell RNA sequencing)
PPIs (protein-protein interactions)
MDFI (MyoD family inhibitor)
ITGB4/LAMB3
AKT
Online Access:https://www.tandfonline.com/doi/10.1080/15384047.2024.2314324

Internet

https://www.tandfonline.com/doi/10.1080/15384047.2024.2314324

Similar Items